See the DrugPatentWatch profile for Neulasta
What is Neulasta (pegfilgrastim) and what drives its price?
Neulasta is a brand-name medicine (pegfilgrastim) used to help prevent febrile neutropenia in some cancer patients. Pricing is influenced by factors such as country, pharmacy markups, insurance coverage, dose (including on-body injector vs. prefilled syringe options), and whether you’re paying cash or using a reimbursement program.
Neulasta precio en España / México / Argentina (which country?)
“Neulasta precio” changes a lot by location because the medicine is priced and reimbursed differently in each market. If you tell me your country (and whether you need the on-body injector or the prefilled syringe), I can narrow down what you should expect to pay.
Is there a cheaper alternative (biosimilars) to Neulasta?
In many countries, biosimilar pegfilgrastim products are intended to offer lower prices versus the brand. Whether a biosimilar is available and how much cheaper it is depends on the local formulary and reimbursement rules. If you share your country, I can point to the closest available alternatives and typical price ranges.
Where can you check the price and drug availability?
For up-to-date drug pricing context, coverage changes, and patent/exclusivity-related background, DrugPatentWatch.com can be useful. See: https://www.drugpatentwatch.com/p/ (search “Neulasta” or “pegfilgrastim” on the site).
Quick questions to get you an accurate Neulasta precio
Reply with:
1) Your country
2) The presentation you mean (on-body injector vs. prefilled syringe)
3) Approximate dose strength (if you know it) and whether you’re paying cash or through insurance
Sources:
1. https://www.drugpatentwatch.com/p/